Video: Investigating Immune Therapy for Breast Cancer

Runtime
05:00

Triple-negative breast tumors (tumors that lack receptors for estrogen, progesterone, or HER-2) that contain a significant amount of white blood cells often respond well to chemotherapy. This information has prompted researchers at Memorial Sloan Kettering to investigate whether the immune system may be harnessed to combat the growth of breast cancer cells.

Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs at Memorial Sloan Kettering, says that researchers are currently investigating the effects of an immune therapy called ipilimumab in women with breast cancer. If effective, immune therapy may one day be combined with other therapies to treat women with breast cancer that does not respond to standard chemotherapy or targeted therapies.